JG
RLAY icon

Jefferies Group’s Relay Therapeutics RLAY Stock Holding History

Jefferies Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$416K – 1940
2020
Q4 		$416K Buy
+10,000
New +$452K ﹤0.01% 1196

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jefferies Group's RLAY Position: Q1 2021 in Review

Jefferies Group sold out of Relay Therapeutics (RLAY) in Q1 2021, closing a stake of 10,000 shares — an estimated $416K sold.

Jefferies Group first reported a position in RLAY in Q4 2020 and held it in 1 quarter. The position peaked at $416K in Q4 2020. 137 funds tracked by Wall St. Rank hold RLAY as of Q1 2021.

  • Jefferies Group reported no remaining Relay Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 10,000 Relay Therapeutics shares in Q1 2021, an estimated $416K.
  • Jefferies Group first reported a position in Relay Therapeutics in Q4 2020 and held it in 1 quarter.
  • Jefferies Group's Relay Therapeutics position peaked at $416K in Q4 2020.
  • 137 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.